Injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) and its antibacterial application

By loading a metal complex formed by diaminothiourea ligand and zinc ions onto folic acid hydrogel, a highly efficient antibacterial injectable hydrogel was prepared, solving the problem of bacterial resistance and achieving effective inhibition of Gram bacteria and support for wound healing.

CN116196468BActive Publication Date: 2024-11-08HENAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310303999.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-27
Publication Date
2024-11-08
Estimated Expiration
2043-03-27

AI Technical Summary

Technical Problem

The overuse of existing antibiotics has led to bacterial resistance, necessitating the development of hydrogel materials with high antibacterial properties and biocompatibility to replace antibiotics in the treatment of bacterial infections.

Method used

By loading diaminothiourea ligands onto folic acid hydrogels and utilizing the metal complex formed by polydopamine and zinc ions, an injectable folic acid-coupled polydopamine hydrogel modified with diaminothiourea was prepared, enhancing its antibacterial effect and improving biocompatibility through electrostatic interactions and hydrogen bonding.

Benefits of technology

The prepared hydrogel exhibits significant antibacterial activity against both Gram-positive and Gram-negative bacteria, and possesses good biocompatibility and injectability. It can continuously release zinc ions for a certain period of time, providing sustained antibacterial effects and reducing cytotoxicity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The present invention relates to synthesizing a novel hydrogel by loading a bis-thiosemicarbazide ligand on a folic acid hydrogel, wherein the bis-thiosemicarbazide ligand HL 1 =2,6-diacetylpyridinium dithiosemicarbazone; HL 2 =2,6-Diacetylpyridine-N 4‑ Methylthiosemicarbazone; the present invention utilizes transition metal ion Zn 2+ An injectable hydrogel was synthesized by cross-linking dopamine, dithiosemicarbazide ligand and folic acid. The two carboxyl groups in the FA molecule and the catechol in polydopamine can easily react with Zn 2+ The metal complex is formed so that the injectable hydrogel matches the shape of the wound. The polydopamine-modified folic acid material is loaded with a bisaminothiourea ligand that has antibacterial effects through electrostatic interactions and hydrogen bonding. Experiments show that compared with blank hydrogels without ligands and ligands alone, the antibacterial effect of the ligand-loaded hydrogel is significantly improved, providing a valuable reference for its application in the antibacterial field.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of hydrogels, and in particular relates to an injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) and its application in antibacterial aspects. Background Art

[0002] Bacterial infection of wounds and inflammatory responses caused by bacteria and fungi are seriously threatening human life safety. In order to solve a series of diseases caused by bacterial infections, a large number of antibiotics have been developed, but the excessive or improper use of antibiotics in recent years has led to the emergence of a variety of drug-resistant microorganisms. Therefore, it is imperative to develop antibacterial biomaterials and use them as substitutes for antibiotics in some cases to alleviate or solve the current problem of bacterial resistance. Among various antibacterial materials, antibacterial hydrogels have attracted more and more attention because of their simple preparation process, diverse structures, excellent biocompatibility and antioxidant properties, and other specific functions, which can replace antibiotics to treat bacterial infectious diseases.

[0003] Hydrogel is a new type of polymer material with a three-dimensional network structure formed by hydrophilic polymer chains through physical action or covalent bond crosslinking. Whether it is a hydrogel formed by natural or synthetic polymers, their three-dimensional network structure can absorb a large amount of water and can still retain a certain amount of water after swelling to equilibrium, and maintain the original structure and performance without dissolving in water. Due to its good biocompatibility, biodegradability, adjustable mechanical properties, high water content, control of tissue adhesion, maintenance of a moist environment at the wound site, and as a physical barrier to bacterial penetration, hydrogel has great advantages in wound healing. Therefore, hydrogel dressings have gradually become a new type of medical dressing in recent years. Among them, the antibacterial function exhibited by antibacterial hydrogels is what we need most in the medical field at present. Antibacterial hydrogels have good antibacterial activity and can provide a moist and heavily hydrated environment for wounds, which can effectively inhibit the growth of microorganisms such as bacteria on the patient's wound surface, thereby effectively reducing the chance of wound infection. Therefore, they are widely used in medical implant device coatings and skin infection treatments to replace traditional antibiotics for bacterial infection treatment, thereby greatly alleviating and eliminating problems such as bacterial resistance.

[0004] Thiosemicarbazone is a 2 -NH-CS-NH 2) is a class of compounds with a wide range of biological activities formed by the condensation of aldehydes or ketones. Since the structure of thiosemicarbazone compounds contains heteroatoms such as N and S, they have a variety of biological activities against bacteria, fungi, viruses, tumors, parasites, etc. In recent years, various thiosemicarbazone compounds have been studied, among which heterocyclic thiosemicarbazone compounds have received widespread attention due to their good biological activity. A large number of studies have shown that the biological activity of thiosemicarbazone compounds is highly dependent on substituents. By changing the structure of aldehydes and ketones or by N 4 The optimization of the substituents at the position can obtain compounds with different biological activities, thereby improving their antibacterial and anticancer activities.

[0005] The present invention focuses on the problem of bacterial infection affecting wound healing and develops an antibacterial hydrogel with good biocompatibility and high antibacterial performance. The present invention uses two bisaminothiourea ligands loaded on folic acid hydrogel to synthesize two new hydrogels. The two carboxyl groups in the folic acid (FA) molecule and the catechol in polydopamine (PDA) can easily react with Zn 2+ A metal complex is formed, in which electrostatic interaction and hydrogen bonding occur between the polydopamine-modified folic acid material and the bisaminothiourea ligand. Experimental verification shows that the antibacterial effect of the ligand-loaded hydrogel is significantly improved compared with the blank hydrogel without ligand loading and the ligand alone. 2 The hydrogel loading ratio is HL 1 The hydrogel has higher antibacterial activity. The present invention then conducted an MTT cytotoxicity test, and the test results showed that the hydrogel had low cytotoxicity, and explored its possible antibacterial mechanism through experiments such as cell membrane integrity, protein leakage, and the generation of reactive oxygen species (ROS). Summary of the invention

[0006] The present invention aims to overcome the defects of the prior art and provide an injectable folic acid-coupled polydopamine hydrogel modified with bisaminothiourea, which has good biocompatibility, excellent antibacterial properties and a simple preparation method.

[0007] The present invention also provides a preparation method of the above-mentioned injectable folic acid-coupled polydopamine hydrogel modified by bis(aminothiourea) and its application in antibacterial aspects.

[0008] To achieve the above object, the present invention adopts the following technical solution:

[0009] A method for preparing an injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea), comprising the following steps:

[0010] 1) Mix folic acid (FA) with water and alkali to obtain solution A;

[0011] 2) Ligand HL1 and / or HL 2 After mixing with dopamine hydrochloride (DA), adding to the alkali solution, then adding dimethyl sulfoxide, stirring and reacting for 20-40 minutes to self-polymerize PDA, obtaining solution B;

[0012] 3) Mix solution A and solution B to obtain solution C;

[0013] 4) Mix the soluble zinc salt solution with solution C to obtain.

[0014] In the injectable folic acid-coupled polydopamine hydrogel modified with bisaminothiourea of ​​the present invention, the two carboxyl groups in the FA molecule and the catechol in polydopamine (PDA) can easily react with Zn 2+ A metal complex is formed, in which electrostatic interaction and hydrogen bonding occur between the polydopamine-modified folic acid material and the bis(aminothiourea) ligand.

[0015] Step 1) may specifically be: 0.1-0.4 g of folic acid is mixed with 4-8 mL of distilled water and 0.05-0.10 g of sodium hydroxide to obtain solution A.

[0016] Specifically, in step 2), the ligand HL 1 is 2,6-diacetylpyridine dithiosemicarbazone, the ligand HL 2 2,6-diacetylpyridine-N 4 -Methylthiosemicarbazone.

[0017] Furthermore, the ligand HL 1 The mass ratio of HL to dopamine hydrochloride is 1:1; the ligand HL 2 The mass ratio of 1:1 to 2 to dopamine hydrochloride.

[0018] Specifically, the amount of dopamine hydrochloride used is 0.02-0.04 g, and the amount of dimethyl sulfoxide used is 15-30 μL.

[0019] Furthermore, in step 4), the soluble zinc salt is zinc acetate, and the concentration of the soluble zinc salt solution is 0.17-0.30 mol / L.

[0020] Specifically, the soluble zinc salt solution is mixed with solution C in a volume ratio of 1:0.8-1.5.

[0021] Furthermore, in step 1) and step 2), the alkali is sodium hydroxide, and the alkali solution is a sodium hydroxide aqueous solution with a concentration of 1-2 mol / L.

[0022] The invention provides an injectable folic acid-coupled polydopamine hydrogel modified by bis-thiosemicarbazide prepared by the preparation method.

[0023] The present invention also provides the application of the injectable folic acid-coupled polydopamine hydrogel modified by bis(aminothiourea) in antibacterial aspects.

[0024] The present invention provides a preferred method for preparing a bis(thiosemicarbazide)-modified injectable folic acid-coupled polydopamine hydrogel, which is specifically as follows:

[0025] 1) Mix 0.1-0.4 g of folic acid with 4-8 mL of distilled water and 0.05-0.10 g of sodium hydroxide and stir for 10 minutes to obtain a transparent brick-red solution A;

[0026] 2) Ligand HL 1 , HL 2 After mixing with 0.02-0.04 g dopamine hydrochloride (ultrasound-assisted dissolution can be used), add it to 1-2 mL of 1 mol / L sodium hydroxide aqueous solution, then add 15-30 μL of dimethyl sulfoxide (DMSO) as a catalyst, stir the reaction for 20-40 minutes to self-polymerize PDA, and obtain a black solution B;

[0027] 3) Mix solution A and solution B to obtain a reddish brown solution C;

[0028] 4) Mix the colorless and transparent zinc acetate solution with a concentration of 0.17-0.30 mol / L with solution C in a volume ratio of 1:0.8-1.5 to obtain the product.

[0029] Folic acid hydrogels are cross-linked by transition metal ions (i.e., Zn 2+ ), dopamine (DA) and folic acid (FA) to synthesize an injectable FA / PDA hydrogel. This injectable hydrogel can match the shape of the wound and has good antibacterial effects on Staphylococcus aureus (typical Gram-positive bacteria) and Escherichia coli (typical Gram-negative bacteria). In addition, this hydrogel can release zinc ions within 12 days, thereby producing a sustained antibacterial effect. Therefore, this antibacterial hydrogel has great potential in rebuilding bacterially infected tissues, especially exposed wounds. Thiosemicarbazone has good antibacterial activity. The present invention combines the ligand HL 1 =2,6-diacetylpyridine dithiosemicarbazone; HL 2 =2,6-diacetylpyridine-N 4 -Methylthiosemicarbazone modified folic acid hydrogels can obtain two types of antibacterial hydrogels, whose antibacterial effects are better than those of the single substance.

[0030] In the process of preparing the composite hydrogel of the present invention, the first step includes mixing the polydopamine solution with the folic acid solution. The second step is to add the ligand thiosemicarbazide compound to the polydopamine solution with the assistance of ultrasound, and dissolve it by ultrasound to form a polydopamine / thiosemicarbazide mixed solution. The third step is Zn2+ Coordinated gelation with folic acid and polydopamine. Since the hydrogel destroys the integrity of the bacterial cell membrane, the cell intracellular tissue outflow occurs, which is likely to cause the death of the bacteria. Secondly, excessive reactive oxygen species (ROS) in bacterial cells will cause a series of oxidative stress reactions and cause bacterial death. After the hydrogel prepared by the present invention is loaded with different dithiosemicarbazones, the formed composite hydrogel material has a bactericidal effect and less cytotoxicity, thereby improving the actual antibacterial efficacy of the hydrogel. . The present invention also carried out a thiazole blue colorimetric (MTT) cytotoxicity test, which showed that the hydrogel had less cytotoxicity; and explored the possible antibacterial mechanism through experiments such as cell membrane integrity, protein leakage, and the generation of reactive oxygen species (ROS).

[0031] The present invention discloses that two new hydrogels are synthesized by loading two bis-aminothiourea ligands on folic acid hydrogels. Considering the excellent biological activity of thiosemicarbazide and the injectable properties of polydopamine-modified folic acid hydrogels, it is reasonable to assume that the resulting composite hydrogel has dual advantages, with both efficient antibacterial properties and excellent injectable properties, as well as good cell activity. 2+ The composite hydrogel was prepared by coordination gelation, and then the composite hydrogel was subjected to antibacterial testing and cell compatibility investigation.

[0032] The present invention produces a HL / PDA solution by mixing DA and HL for self-polymerization; then the above solution is mixed with a FA solution to obtain a FA / HL / PDA solution; and then a one-step synthesis method is used to synthesize Zn 2+ The solution was mixed with the FA / HL / PDA solution to obtain the FA / HL / PAD hydrogel, and the antibacterial efficacy against Escherichia coli, Bacillus cereus, Staphylococcus aureus, Agrobacterium tumefaciens, Bacillus subtilis, etc. was evaluated, and its mechanism of action was explored, and cell activity tests were performed. Compared with the prior art, the present invention has the following beneficial effects:

[0033] 1) This invention is the first to develop a method for introducing transition metal ions Zn 2+ As a coordinating ion for gelation, and adding highly effective antibacterial ligands into the hydrogel, a novel green synthetic strategy for injectable bis(aminothiourea)-modified folic acid-coupled polydopamine hydrogel was constructed;

[0034] 2) The folic acid FA used in the present invention is a natural substance essential to the human body, which has anti-tumor effects and G-quadruplex formation properties. In addition, another natural substance, dopamine (DA) and its polymer form, polydopamine (PDA), have a wide range of applications in tissue engineering and other biomedical fields. Since PDA has a highly reactive catechol group, it is often used to prepare hydrogels with self-healing functions. Zinc ions (Zn 2+ ) exhibits excellent antibacterial properties and synergistic and tissue repair capabilities. Bisaminothiourea has a wide range of pharmacological activities, such as anti-tumor, antibacterial, antiviral, and antimalarial. Therefore, the synthesized composite hydrogel has excellent properties such as antibacterial, injectable, and wound healing. 2 + ), cross-linked bis(thiosemicarbazide) ligand (HL), dopamine (PDA) and folic acid (FA) to synthesize an injectable composite hydrogel, which provides a realistic basis;

[0035] 3) The composite hydrogel prepared by the present invention has high bactericidal efficiency and good biocompatibility, and can maintain a high therapeutic effect for a certain period of time;

[0036] 4) The injectable folate-coupled polydopamine hydrogel modified with bisaminothiourea prepared by the present invention has certain antibacterial efficacy against Gram-positive and Gram-negative bacteria, and the antibacterial activity of a series of hydrogels with different ligand-polydopamine ratios is explored and compared. The present invention systematically explains its possible antibacterial mechanism. The composite hydrogel of the present invention will have great application prospects in the biomedical field;

[0037] 5) The injectable folic acid-coupled polydopamine hydrogel modified by bisaminothiourea prepared by the present invention is injectable, can fit the wound perfectly, and also has application prospects in the field of rapid wound repair. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 A brief description of the synthesis route of the composite hydrogel of the present invention;

[0039] Figure 2 (a) is HL 1 , FA / PDA, FA / HL 1 IR spectrum of / PDA, (b) HL 1 , FA / PDA, FA / HL 1 / PDA, X-ray powder diffraction, (c) HL 2 , FA / PDA, FA / HL 2 / PDA1, FA / HL 2 / PDA 1.5, FA / HL 2 / IR spectrum of PDA 2, (d) is HL 2 , FA / PDA, FA / HL 2 / PDA1, FA / HL 2 / PDA 1.5, FA / HL 2 / X-ray powder diffraction of PDA 2;

[0040] Figure 3 a, b, c, and d are FA / PDA and FA / HL respectively. 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 / SEM image of PDA 1.5 hydrogel;

[0041] Figure 4 FA / HL 2 / PDA 1 hydrogel mapping;

[0042] Figure 5 FA / HL 2 X-ray photoelectron spectroscopy (XPS) of / PDA 1 hydrogel;

[0043] Figure 6 For FA / PDA, FA / HL 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 / PDA 1.5, FA / HL 2 / Disc antibacterial effect of PDA 2 hydrogel on Escherichia coli, Staphylococcus aureus, Bacillus cereus, and Agrobacterium tumefaciens;

[0044] Figure 7 For FA / PDA, HL 1 , FA / HL 1 / PDA, HL 1 , FA / HL 2 / PDA 1, FA / HL 2 / PDA 2 hydrogel's antibacterial effect on Bacillus subtilis, Agrobacterium tumefaciens, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Bacillus cereus;

[0045] Figure 8 For FA / HL 2 / PDA 1 hydrogel treated Escherichia coli antibacterial mechanism; (a) the integrity of the cell membrane at an optical density of 260 nm, the effect of the composite material on the damage of the bacterial cell membrane, (b) the effect of the composite material on the protein leakage in the cell membrane at an optical density of 595 nm, (c) the effect of the composite material on the activity of the intracellular respiratory chain dehydrogenase at an optical density of 490 nm, (d) the generation of intracellular reactive oxygen species caused by the composite material at an optical density of 575 nm, (e) the effect of the composite material on the change of intracellular glutathione (GSH) content at an optical density of 412 nm;

[0046] Fig. 9 For FA / PDA, FA / HL 1 / PDA、FA / HL 2 / PDA 1 hydrogel cytotoxicity;

[0047] Fig.10 FA / HL 2 / Diagram of injectability of PDA 1 hydrogel. DETAILED DESCRIPTION

[0048] The technical solution of the present invention is further described in detail below in conjunction with the embodiments, but the protection scope of the present invention is not limited thereto.

[0049] In the following examples, folic acid and dopamine hydrochloride were purchased from Beijing Bailingwei Technology Co., Ltd., and 2,6-diacetylpyridine was purchased from J&K Chemical Co., Ltd. 4-Methyl-3-thiosemicarbazide and thiosemicarbazide were purchased from Beijing Bailingwei Technology Co., Ltd. The antibacterial performance, mechanism and other detection tests involved, unless otherwise specified, were determined using conventional techniques in the art.

[0050] Embodiment 1:

[0051] Injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) (FA / HL / PDA), wherein the chemical name of the bis(aminothiourea) ligand is: HL 1 =2,6-diacetylpyridine dithiosemicarbazone; HL 2 =2,6-diacetylpyridine-N 4 -methylthiosemicarbazone, the amino group in FA and the catechol group in PDA form hydrogen bonds to connect with the PDA chain, in addition, the primary amino group in FA and the quinone group in PDA can also form hydrogen bonds, the amino group in bis-thiosemicarbazone can form hydrogen bonds with the catechol group in PDA, the two carboxyl groups in the FA molecule and the catechol in polydopamine PDA can easily form hydrogen bonds with Zn 2+ A metal complex is formed to form a composite hydrogel material (FA / HL / PDA).

[0052] (1) Ligand bis(aminothiourea) (HL 1 , HL 2 )

[0053] HL 1 = Preparation method of 2,6-diacetylpyridine dithiosemicarbazone: weigh 0.2 g of 2,6-diacetylpyridine and 0.22 g of thiosemicarbazone and dissolve them in a 50 mL round-bottom flask containing 30 mL of anhydrous ethanol, add 110 μL of glacial acetic acid as a catalyst, stir at 70 °C on a reflux heating stirrer for 4 hours, cool to room temperature and then filter, collect the product after drying to obtain a ligand.

[0054] HL 2 =2,6-diacetylpyridine-N 4 Preparation method of -methylthiosemicarbazone: Weigh 2,6-diacetylpyridine (0.2 g, 2 mmol) and 4-methyl-3-thiosemicarbazone (0.22 g, 2 mmol) and place them in a 50 mL round-bottom flask, add 30 mL of ethanol, add 110 μL of glacial acetic acid dropwise, stir and reflux at 70 °C for 4 hours, cool to room temperature and filter to obtain a light yellow powder solid, which is the ligand.

[0055] (2) The present invention provides a method for preparing an injectable folate-coupled polydopamine hydrogel modified with bis(aminothiourea), which specifically comprises the following steps (synthetic route see Figure 1 ):

[0056] 1) Add 0.18 g of folic acid FA to 4 mL of distilled water, add 0.05 g of sodium hydroxide, and stir the mixed solution for 10 min until the solution becomes transparent to obtain a transparent brick-red solution A. In this step, FA dissolves in alkaline water to form folate, and hydrogen bonds between folic acid molecules form a long chain of folic acid molecules.

[0057] 2) Before gelation, the ligand HL 1 (0.02g), HL 2 (0.02g) and dopamine hydrochloride DA (0.02g, 0.03g, 0.04g) were respectively HL 1 :DA=1:1,HL 2 :DA=1:1, 1:1.5, 1:2 were mixed and added to 1 mL of 1 mol / L sodium hydroxide aqueous solution, 20 μL of dimethyl sulfoxide (DMSO) was added to the mixed solution as a catalyst, and stirred for 20 min to self-polymerize HL / PDA solution (the solution was black after stirring), and a black solution B was obtained; this step is the polymerization process of D, that is, the catechol group and the quinone group in the DA molecule react with each other to form a PDA chain;

[0058] 3) Mix solution A and solution B to obtain a reddish brown solution C; this step is to add the FA solution prepared in the first step to the PDA reagent to connect each FA long chain to form a network structure, which is the FA-PDA complex;

[0059] 4) Take 0.385 g of zinc acetate and dissolve it in 10 mL of distilled water. Stir to form a colorless and transparent zinc acetate solution (concentration 0.21 mol / L).

[0060] 5) Mix the zinc acetate solution and solution C at a volume ratio of 1:1 to form sample hydrogels FA / HL containing different mass concentrations of polydopamine 1 / PDA、 FA / HL 2 / PDA(FA / HL 2 / PDA 1, FA / HL 2 / PDA 1.5, FA / HL 2 / PDA2).

[0061] In addition, the present invention studies the injectable properties of the hydrogel, and uses the FA / HL prepared above as an example. 2 / PDA1 hydrogel product was used as an example for relevant experiments: First, a syringe was used to draw an appropriate amount of FA / HL 2 / PDA1 hydrogel sample, then slowly push the syringe and observe the phenomenon. Fig.10 Given FA / HL 2 Figure 1. Injectability of PDA 1 hydrogel. Fig.10 As shown, FA / HL is shown as being sucked into the syringe but not injected at 0S. 2 / PDA1 hydrogel sample, FA / HL in part of the volume can be seen at 5S 2 / PDA1 hydrogel sample was pushed out through a syringe, and the results showed that: 2 / PDA1 hydrogel has certain injectability.

[0062] As a comparison, the present application provides a synthesis of a folic acid hydrogel, which is prepared by the following steps:

[0063] 1) Add 0.18 g of folic acid to 4 mL of distilled water, add 0.05 g of sodium hydroxide, and stir the mixed solution for 10 min until the solution becomes transparent to obtain a transparent brick-red solution A;

[0064] 2) Add 0.02 g of dopamine hydrochloride to 1 mL of 1 mol / L sodium hydroxide aqueous solution, add 20 μL of dimethyl sulfoxide (DMSO) to the mixed solution, and stir for 20 min to self-polymerize PDA (the solution turns black after stirring) to obtain a black solution B;

[0065] 3) Mix solution A and solution B to obtain a reddish brown solution C;

[0066] 4) Dissolve 0.385 g of zinc acetate in 10 mL of distilled water and stir to form a colorless and transparent acetic acid solution (0.21 mol / L);

[0067] 5) Zinc acetate and solution C were mixed in a volume ratio of 1:1 to form folic acid hydrogel (FA / PDA hydrogel).

[0068] Figure 3 The middle ad is FA / PDA, FA / HL 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 SEM image of / PDA 1.5 hydrogel. Figure 3 It can be seen that Figure 3 The FA / PDA hydrogel alone shown in (a) exhibits a smooth surface and stacked nanosheets as well as a large porous structure. 1 / PDA hydrogel and FA / / HL 2 / PDA1 hydrogel( Figure 3 The surfaces of (b) and (c) show obvious wrinkles, which are related to the electrostatic interaction between the carboxyl groups of the hydrogel and the imino groups of the bis(aminothiourea). In addition, the SEM element mapping of C, O, N, and S is shown in Figure 2. Figure 4 As shown, the successful formation of the composite material was demonstrated.

[0069] Figure 2 In the figure, a and b are FA / PDA and HL respectively. 1 , FA / HL 1 Infrared spectrum and X-ray powder diffraction of / PDA, c and d are HL 2 , FA / PDA, FA / HL 2 / PDA1, FA / HL 2 / PDA 1.5, FA / HL 2 Infrared spectrum and X-ray powder diffraction of / PDA 2. Figure 2 As shown in (a), FA / PDA hydrogel has a peak at 1654 cm -1 A broad peak appears at 1577 cm, which is due to the stretching vibration of C=O. -1The absorption peak at is attributed to the NH bending vibration. 1 In the spectrum of -1 The absorption peaks at 1163 cm -1 The absorption peaks belong to NN stretching vibration, 821 cm -1 The absorption peak belongs to C=S stretching vibration. 1 / 1185cm in PDA spectrum −1 The characteristic signal spectrum at is attributed to HL 1 NN in FA / HL 1 / Successful synthesis of PDA. 2 , FA / PDA, FA / HL 2 / PDA1, FA / HL 2 / PDA 1.5, FA / HL 2 The FT-IR spectrum of PDA 2 is shown in Figure 2 As shown in c, HL 2 The absorption peaks at 1554, 1103 and 867 cm-1 are respectively attributed to v (C=N))、 v (NN) and v (C=S). For FA / PDA hydrogel, at 1586 cm -1 The absorption peak at v ((NH). In FA / HL 2 / PDA 1.5 hydrogel, HL 2 The N–N and N–H stretching vibration bands in the -1 and 1586cm -1 , this is due to the effect of hydrogen bonding. In addition, HL 2 The typical characteristic absorption peak of FA / PDA hydrogel appears in FA / HL 2 / PDA hydrogel, indicating that HL 2 The successful combination of FA / PDA hydrogel. The positions of the corresponding diffraction peaks were compared by XRD spectroscopy to further prove the phase purity and similarity of the obtained crystalline compounds. It was used to confirm the phase purity of the hydrogel. Figure 2 As can be seen in b, FA / HL 1 / PDA hydrogel showed similar 1 The diffraction peaks of FA / HL 1 The presence of HL in the PDA hydrogel 1 .like Figure 2 As shown in d, for HL 2 The XRD spectrum shows that the 0 ,14.990 Two peaks. 2 / PDA XRD spectrum shows that 2θ = 9.98 0 A broad peak appears at FA / HL 2 / PDA hydrogel was successfully prepared without any other impurities.

[0070] X-ray photoelectron spectroscopy (XPS) technology was used to study its chemical composition and the valence state of related elements. Figure 5 As shown, the prepared FA / HL 2 The / PDA1 hydrogel sample is composed of C, N, O, S and Zn elements, which are uniformly dispersed in the prepared hydrogel. The XPS spectrum of N 1s shows two obvious peaks at 398.7 and 399.4 eV, which belong to pyridine-N and triazine-N, respectively. In addition, two satellite peaks appear at 163.1 eV and 164.1 eV in the S 2p XPS spectrum, which belong to C=S, further proving that FA / HL 2 Successful preparation of / PDA1 hydrogel.

[0071] Embodiment 2:

[0072] Study on antibacterial properties: The antibacterial properties were first evaluated by disk diffusion method, with typical Gram-negative bacteria (Escherichia coli E.coi , Agrobacterium tumefaciens A. tumefaciena ) and Gram-positive bacteria (Staphylococcus aureus S. aureus , Bacillus cereus B.cereu ) FA / PDA, FA / HL of the present invention 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 / PDA 1.5, FA / HL 2 The antibacterial properties of FA / PDA 2 hydrogels were evaluated. FA / PDA hydrogels were used as the blank control group, and those loaded with different amounts of dopamine were used as the experimental groups. Figure 6 As shown, under the same experimental conditions, FA / HL 1 / PDA hydrogel and FA / HL 2 The antibacterial property of FA / PDA hydrogel is better than that of FA / PDA hydrogel, indicating that the ligand-loaded hydrogel has good antibacterial activity. 1 / PDA comparison, FA / HL 2 / PDA hydrogel has good antibacterial performance, FA / HL 1 / PDA and FA / HL 2 / PDA has good antibacterial activity against Staphylococcus aureus and Bacillus cereus.2 / PDA hydrogel's antibacterial properties. The experimental results show that with the increase of dopamine content, the inhibition zone has no obvious change, indicating that the antibacterial effect of the composite hydrogel has no obvious enhancement.

[0073] Embodiment 3:

[0074] The antibacterial properties of the composite hydrogel were evaluated by colony counting method. 1 , HL 2 , FA / PDA, FA / HL 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 / PDA 2 against Bacillus subtilis ( B. subtilis ), Agrobacterium tumefaciens ( A. tumefaciena ), Pseudomonas aeruginosa ( P. aeruginosa ) and Bacillus cereus ( B.cereu ), Escherichia coli ( E.coi ) and Staphylococcus aureus ( S. aureus ) has an antibacterial effect. Figure 7 As shown, by exploring HL 1 , HL 2 The antibacterial properties of the three hydrogel materials, FA / PDA, were investigated. The results showed that the three hydrogel materials had certain antibacterial effects on Escherichia coli, Agrobacterium tumefaciens, Bacillus subtilis, Staphylococcus aureus and Bacillus cereus. 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 The antibacterial effect of FA / HL hydrogel on Enterobacter, Agrobacterium tumefaciens, Bacillus subtilis, Staphylococcus aureus and Bacillus cereus was shown. 1 / PDA、FA / HL 2 / PDA 1, FA / HL 2 The colony counts of Escherichia coli, Agrobacterium tumefaciens, Bacillus subtilis, Staphylococcus aureus and Bacillus cereus cultured on PDA 2 were greatly reduced, and the antibacterial effect was significantly enhanced. For Escherichia coli (Gram-negative bacteria) and Staphylococcus aureus (Gram-positive bacteria), the ligand HL 2 FA / HL 2 The antibacterial effect of / PDA hydrogel is significantly higher than that of HL loaded with ligand 1 FA / HL 1 / PDA hydrogel.

[0075] Embodiment 4:

[0076] Antibacterial mechanism experiment: bacterial cell membrane integrity test. Antimicrobial agents can directly interact with bacterial cell membranes, thereby destroying the integrity of cell membranes, which may lead to the leakage of nutrients and ultimately cell death. The release of small components and low molecular weight substances, including K+, PO 4 2− , DNA and RNA, destroying or impairing the function of cells. The outflow of intracellular components, such as DNA and RNA, can show specific absorption at 260nm. Therefore, the optical density value at 260nm can be determined as an indicator of bacterial membrane integrity. The E. coli group without composite hydrogel treatment was used as a blank control group and was treated with FA / HL 2 / PDA 1 treated E. coli group was used as the experimental group. Figure 8 As shown in a, the optical density values ​​at 260 nm of the control group after culturing for 0 min, 15 min, and 15 min were similar. 260 nm ) increased significantly, indicating that the composite hydrogel FA / HL 2 / PDA 1 can cause serious damage to the bacterial membrane. The integrity of the cell membrane is destroyed, causing some components in the bacteria to leak.

[0077] Antibacterial mechanism experiment: protein leakage test. Once the bacterial cell wall / membrane is damaged, the protein inside the bacterial cell will leak out of the cell. Therefore, protein leakage can be used as an indicator of cell wall / membrane integrity damage. Based on OD 595 nm The protein leakage was assessed by measuring the absorbance at 400 nm to monitor the integrity of the cell membrane. Figure 8 As shown in b, the optical density values ​​(OD 595 nm ) changed little, while the experimental group increased significantly, which also showed that the addition of 2,6-diacetylpyridine N 4 After methylthiosemicarbazone-modified folic acid was coupled to polydopamine hydrogel, protein leakage increased significantly, which once again proved that it could damage the bacterial cell membrane and cause bacterial death. This is consistent with the results of the determination of bacterial cell membrane integrity.

[0078] Antibacterial mechanism experiment: Activity experiment of respiratory chain dehydrogenase. Under physiological conditions, bacterial respiratory chain dehydrogenase can reduce colorless iodonitrotetrazolium (INT) to dark red water-insoluble iodonitrotetrazolium (INF). Therefore, the optical density value (OD 490 nm ) to determine the activity of respiratory chain dehydrogenases, such as Figure 8 As shown in c, FA / HL 2After being treated with FA / HL composite hydrogel, the enzyme activity of Escherichia coli was much lower than that of the control group, and the respiratory chain dehydrogenase activity of normal cells increased during the incubation process. These results confirmed that FA / HL 2 / PDA 1 composite hydrogel may inhibit the activity of respiratory chain dehydrogenases.

[0079] Antibacterial mechanism experiment: Reactive oxygen species (ROS) content. When there is an excess of reactive oxygen species (ROS) in cells, a series of reactions will occur, leading to bacterial death, such as oxidative damage and oxidative stress. In addition, ROS will also affect the proteins and nucleic acids of bacterial cells. The present invention further understands the FA / HL by measuring the content of ROS in bacterial cells. 2 The antibacterial mechanism of / PDA 1 composite hydrogel. 2– Under the action of (a type of ROS), nitrobenzene blue tetrazolium (NBT) can be reduced to blue-purple formaldehyde. Therefore, the amount of blue-purple formaldehyde generated can be used to indicate the level of ROS in bacterial cells. Therefore, the present invention uses the nitrobenzene blue tetrazolium (NBT) reduction method to measure the changes in the content of active oxygen in bacterial cells. Figure 8 As shown in Figure d, after 15 min of incubation, the production of ROS in untreated E. coli cells remained essentially unchanged. 2 In the presence of the PD-1 / PDA 1 composite hydrogel, the generation of ROS increased significantly with the increase of incubation time. If it is not discarded in time, it will lead to the accumulation of ROS and cause a series of oxidative stress reactions, eventually leading to cell death.

[0080] Antibacterial mechanism experiment: Glutathione (GSH) oxidation test. GSH is a tripeptide containing a thiol group, which can act as an antioxidant in bacteria to prevent damage to cellular components caused by oxidative stress. The thiol group (-SH) in GSH can be converted into a disulfide bond (-SS-) by oxidation, thereby converting GSH into a glutathione disulfide bond. Therefore, glutathione (GSH) has been used as an indicator of intracellular oxidative stress. The Ellman method can be used to quantitatively detect the concentration of thiol groups in GSH. The formation of glutathione disulfide can be used as an indicator of GSH loss. Such as Figure 8 As shown in Figure e, after 1 h of culture, the absorbance at 412 nm decreased significantly, indicating that the GSH content decreased significantly and the degree of GSH oxidation increased significantly. The results showed that FA / HL 2 The α / PDA1 hydrogels either directly converted GSH to GSSG or induced the formation of ROS, which in turn converted GSH to GSSG. Ultimately, the depletion of GSH was responsible for the bacterial cell damage.

[0081] Embodiment 5:

[0082] The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium) assay is used to detect cytotoxicity. The MTT assay principle involves the succinate dehydrogenase in the mitochondria of living cells converting the water-soluble dye MTT into insoluble formazan and depositing it in the cells, while dead cells do not have this function. The formazan is then dissolved with DMSO and the optical density at 490 nm is detected. The present invention detects the cytotoxicity of composite hydrogels, FA / HL 1 / PDA1, FA / HL 2 / PDA1 cytotoxicity to lung cancer cells (A594) and neuroblastoma cells (SK-N-SH). Fig. 9 As shown in Figure 3, the cell viability of the thiosemicarbazide hydrogels was only slightly decreased compared with the blank control group (FA / PDA). This indicates that the local and sustained action of the thiosemicarbazide functionalized polydopamine-coupled hydrogels can lead to certain toxicity, but will not cause serious damage.

[0083] In summary, the present invention focuses on the problem of bacterial infection and wound infection and develops a semicarbazide-modified dopamine-coupled folic acid hydrogel with high antibacterial properties. 2+ ) is a transition metal ion that has a high binding constant with FA or catechol, and has good coordination and antibacterial properties and tissue repair ability. The present invention utilizes the two carboxyl groups in the FA molecule or the catechol in PDA to easily chelate Zn 2+Metal ligand coordination is formed, so that FA / PDA hydrogel is formed in only a few seconds. Semicarbazide is a N, N, S tridentate Schiff base ligand with good antibacterial properties. Hydrogen bonds can be formed between PDA and semicarbazide, and semicarbazide is successfully modified to polydopamine through hydrogen bonding, and then the antibacterial performance test is carried out, and the synthesized semicarbazide modified dopamine coupled folic acid hydrogel can release zinc ions within a certain period of time, so the folic acid hydrogel synthesized by the present invention has a certain wound repair ability. The composite hydrogel has injectable properties and maintains a certain stability; in addition, the composite hydrogel has the advantages of injectability, low toxicity, and easy operation, and its application in the field of antibacterial provides a valuable reference. The synthesis route of the semicarbazide functionalized polydopamine coupled folic acid hydrogel in the present invention is as follows: the first step is to dissolve FA in alkaline water (brown) and convert the two carboxyl groups of FA into carboxylic acid functions. The hydrogen bonding interaction of FA molecules also combines two FA molecules, so that the FA molecules form a long chain. DA is introduced to connect each long chain to form a network structure. The second step is the polymerization process of DA, that is, the catechol and quinone groups in the DA molecule react with each other to form a PDA chain. In the third step, thiosemicarbazide functionalizes polydopamine, and hydrogen bonds are formed between thiosemicarbazide and polydopamine. In the fourth step, zinc ions are added, and the zinc ions and the two carboxyl groups in the FA molecule or the catechol in the PDA form coordination, and a hydrogel is formed in a few seconds. Since the polydopamine functionalized with thiosemicarbazide has excellent antibacterial properties, the hydrogel composite material is endowed with a stronger antibacterial effect. The polydopamine-coupled folic acid hydrogel modified with thiosemicarbazide has good injectability, and direct contact with the bacterial suspension can cause physical damage to its cell membrane, thereby destroying the integrity of the bacterial cell membrane and causing leakage of components in the cytoplasm. The prepared composite material has a certain wound repair ability due to the sustainable release of zinc ions. In short, the composite hydrogel prepared by the present invention has efficient antibacterial ability, good injectability, and may have a certain wound repair ability, and has less cytotoxicity. The hydrogel prepared by the present invention is expected to become an efficient antibacterial biomaterial.

Claims

1. A method for preparing an injectable folic acid-coupled polydopamine hydrogel modified with bis(thiosemicarbazide), characterized in that: The steps include: 1) Mix folic acid with water and alkali to obtain solution A; 2) Ligand HL 2 After mixing with dopamine hydrochloride, add into alkali solution, then add dimethyl sulfoxide, stir and react for 20-40 minutes to obtain solution B; 3) Mix solution A and solution B to obtain solution C; 4) Mix the soluble zinc salt solution with solution C to obtain; The ligand HL 2 It is 2,6-diacetylpyridine-N4-methylthiosemicarbazone; The prepared bis(aminothiourea) modified injectable folic acid-coupled polydopamine hydrogel has antibacterial efficacy, and the bacteria include one or more of Escherichia coli, Pseudomonas aeruginosa, Agrobacterium rhizogenes, Staphylococcus aureus, Bacillus subtilis, and Bacillus cereus.

2. The method for preparing the injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) as claimed in claim 1, characterized in that: Step 1) is specifically as follows: 0.1-0.4 g of folic acid is mixed with 4-8 mL of distilled water and 0.05-0.10 g of sodium hydroxide to obtain solution A.

3. The method for preparing the injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) as claimed in claim 2, characterized in that: The ligand HL 2 The mass ratio of 1:1 to 2 to dopamine hydrochloride.

4. The method for preparing the injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) as claimed in claim 3, characterized in that: The amount of dopamine hydrochloride used is 0.02-0.04 g, and the amount of dimethyl sulfoxide used is 15-30 μL.

5. The method for preparing the injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) as claimed in claim 4, characterized in that: In step 4), the soluble zinc salt is zinc acetate, and the concentration of the soluble zinc salt solution is 0.17-0.30 mol / L.

6. The method for preparing the injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) as claimed in claim 5, characterized in that: The soluble zinc salt solution is mixed with solution C in a volume ratio of 1:0.8-1.

5.

7. The method for preparing the injectable folic acid-coupled polydopamine hydrogel modified with bis(thiosemicarbazide) as claimed in claim 1, characterized in that: In step 1) and step 2), the alkali is sodium hydroxide, and the alkali solution is a sodium hydroxide aqueous solution with a concentration of 1-2 mol / L.

8. An injectable folate-coupled polydopamine hydrogel modified with bisaminothiourea prepared by the preparation method according to any one of claims 1 to 7.

9. The use of the injectable folic acid-coupled polydopamine hydrogel modified with bis(aminothiourea) as claimed in claim 8 in antibacterial aspects, characterized in that: The bacteria include one or more of Escherichia coli, Pseudomonas aeruginosa, Agrobacterium tumefaciens, Staphylococcus aureus, Bacillus subtilis, and Bacillus cereus.